Is CG Oncology (CGON) Stock Pricing In Its Recent 79% One Year Surge? [Yahoo! Finance]
CG Oncology, Inc. - Common stock (CGON)
Company Research
Source: Yahoo! Finance
The stock recently closed at US$54.20, with returns of 29.7% over the last 7 days, 29.9% over the last 30 days, 29.7% year to date, and 79.5% over the last year. Recent attention on CG Oncology has been driven by its position in the pharmaceuticals and biotech space, along with growing interest from investors following its stock price moves. This context is important when thinking about how much of the story might already be reflected in the current share price. On Simply Wall St's valuation checks, CG Oncology currently has a valuation score of 3 out of 6 . This suggests some areas of potential undervaluation that we will unpack next, followed by a perspective on a more complete way to think about value. CG Oncology delivered 79.5% returns over the last year. See how this stacks up to the rest of the Biotechs industry. A DCF model estimates what a company might be worth by projecting its future cash flows and discounting them back to today, so you can compare that value to t
Show less
Read more
Impact Snapshot
Event Time:
CGON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGON alerts
High impacting CG Oncology, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CGON
News
- CG Oncology (NASDAQ:CGON) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene [Seeking Alpha]Seeking Alpha
- CG Oncology (CGON) Is Up 29.7% After Accelerating PIVOT-006 Phase 3 Timeline - Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- CG Oncology (NASDAQ:CGON) was given a new $93.00 price target on by analysts at Morgan Stanley.MarketBeat
- CG Oncology (NASDAQ:CGON) was given a new $66.00 price target on by analysts at Truist Financial Corporation.MarketBeat
CGON
Earnings
- 11/14/25 - In-Line
CGON
Sec Filings
- 1/13/26 - Form 8-K
- 1/13/26 - Form 424B5
- 1/13/26 - Form 4
- CGON's page on the SEC website